Stock Chart
GRAL
Type: SELL wallstreet
Strike: $80
Premium: $10.65
Expiry: Jan 15, 2027
Target: $83
Score: -68
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About GRAL - GRAIL, Inc. Common Stock
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Key Statistics
More GRAL Analysis
This GRAL stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track GRAL's price movements with trendlines, gamma walls, and key support/resistance levels.